Teenagers fear blindness more than lung cancer

Article

Fear of going blind may be more likely to motivate teenagers to stop smoking than the fear of heart or lung disease.

Fear of going blind may be more likely to motivate teenagers to stop smoking than the fear of heart or lung disease, according to a report published online ahead of print by the British Journal of Ophthalmology.

Simon Kelly from the Bolton Eye Unit, UK, led a collaboration of UK and New Zealand based researchers who developed a cross-sectional survey using a structured interview of teenagers attending four organised social events. They investigated the awareness and fear of blindness, lung cancer, heart disease, stroke and a distracter condition (deafness). The aim was to establish the likelihood of whether smokers would quit on developing early signs of the various conditions.

Of the 260 16- to 18-year olds that were interviewed, 15%, 27% and 81% believed smoking caused stroke, heart disease and lung cancer, respectively. Just 5% thought that smoking caused blindness. Subjects were asked to rank their fear of each of the conditions, a score of five for the most feared and one for the least feared. Researchers found that subjects were significantly more fearful of blindness than of lung cancer, heart disease and deafness. Additionally, more teenagers said they would give up smoking if they developed early signs of blindness.

The researchers concluded that emphasizing the risk of blindness is more likely to encourage teenagers to stop smoking than by stressing the risks of lung and hearts disease.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.